To Evaluate the Efficacy and Safety of Wenxin Keli in Treating Atrial Premature Beats
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 288 participants.
Also called NCT02319603
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 288 participants
- Registry
-
NCT02319603
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT02319603. Randomized; double masking; primary purpose treatment. Start 2015-01 (registry gives no type); primary completion 2017-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Evaluate the Efficacy and Safety of Wenxin Keli in Treating Atrial Premature Beats
- Condition
- Atrial Premature Beats
- Intervention (Drug)
- Low dose WenXin keli
- Intervention (Drug)
- High dose WenXin keli
- Lead sponsor
- Beijing Bozhiyin T&S Co., Ltd.
Record details
- Record id
cardio:ct-nct02319603- Content hash
89d900c69d9a004fb2f0c353a0913fc920897401deace5dc062d8da0626f50eb